Shopping Cart
- Remove All
Your shopping cart is currently empty
Ibiglustat (L-Malic acid) (Ibiglustat L-Malic acid) is a selective, brain-penetrant, and allosteric inhibitor of glucosylceramide synthase. Ibiglustat (L-Malic acid) can be used in studies about PD Parkinson's disease, SRT in Fabry's and Gaucher's.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $55 | In Stock | |
| 2 mg | $80 | In Stock | |
| 5 mg | $155 | In Stock | |
| 10 mg | $229 | In Stock | |
| 25 mg | $387 | In Stock | |
| 50 mg | $575 | In Stock | |
| 100 mg | $823 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $179 | In Stock |
| Description | Ibiglustat (L-Malic acid) (Ibiglustat L-Malic acid) is a selective, brain-penetrant, and allosteric inhibitor of glucosylceramide synthase. Ibiglustat (L-Malic acid) can be used in studies about PD Parkinson's disease, SRT in Fabry's and Gaucher's. |
| In vitro | Ibiglustat (L-Malic acid) (1 μM) treated Fabry disease cells are close to the physiological level in untreated WT cells in GL-3 levels. Ibiglustat (L-Malic acid) prevents additional GL-3 accumulation and ameliorates the abundant GL-3 levels in FD cardiomyocytes[4]. |
| Synonyms | Venglustat (L-Malic acid), SAR402671 (L-Malic acid), Ibiglustat L-Malic acid, GZ402671 (L-Malic acid) |
| Molecular Weight | 523.57 |
| Formula | C24H30FN3O7S |
| Cas No. | 1629063-78-0 |
| Smiles | O[C@@H](CC(O)=O)C(O)=O.CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)c1csc(n1)-c1ccc(F)cc1 |
| Relative Density. | no data available |
| Storage | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 90 mg/mL (171.9 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.